Hexagon Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-73
Closed -$17.8K 263
2025
Q1
$17.8K Buy
73
+1
+1% +$301 ﹤0.01% 794
2024
Q4
$23.7K Hold
72
﹤0.01% 733
2024
Q3
$24.1K Hold
72
﹤0.01% 647
2024
Q2
$19.7K Hold
72
﹤0.01% 691
2024
Q1
$24.9K Hold
72
0.01% 616
2023
Q4
$23.2K Hold
72
0.01% 587
2023
Q3
$25.8K Hold
72
0.01% 495
2023
Q2
$27.3K Hold
72
0.01% 483
2023
Q1
$34.5K Hold
72
0.01% 426
2022
Q4
$30.3K Hold
72
0.01% 452
2022
Q3
$30K Hold
72
0.01% 496
2022
Q2
$36K Hold
72
0.01% 424
2022
Q1
$41K Hold
72
0.01% 397
2021
Q4
$54K Hold
72
0.01% 351
2021
Q3
$54K Hold
72
0.02% 337
2021
Q2
$46K Hold
72
0.01% 339
2021
Q1
$41K Hold
72
0.01% 327
2020
Q4
$41K Hold
72
0.01% 293
2020
Q3
$42K Buy
+72
New +$36.5K 0.01% 273

Other funds holding BIO